Tooth Fairy
Natural health product licensed in Canada
- Other names
- Xyli Tooth
- Licence holder
- 1180056 B.C. Ltd.
- NPN or DIN-HM
- 80097730
- Status
- Active licence
- Licence date
- 20 March 2020
- Revision date
- Not provided
- Form
- Comprimé, à croquer
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Carboxyméthylcellulose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 9 years ; maximum: 13 years | 1 Comprimé | 4 |
| Enfants | minimum: 4 years ; maximum: 9 years | 1 Comprimé | 4 |
| Enfants | minimum: 3 years ; maximum: 6 years | 1 Comprimé | 4 |
Uses authorised in Canada
Helps to prevent dental carries. Helps reduce the incidence of cavities. Stimulates saliva production to relieve dryness of the mouth. Helps reduce colonization of oral cavity by caries-causing bacteria (Mutans streptococci).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
A gradual introduction to xylitol is recommended since xylitol could have a mild laxative effect. Discontinue use if gastrointestinal discomfort occurs.
Source
Official Health Canada record, licence 80097730
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.